A Study of Efficacy and Safety of Ocrelizumab in Patients with Relapse-Remitting Multiple Sclerosis ClinicalTrials.gov, 14 Nov 2011 Accessed on 7 Dec 2011 from http://clinicaltrials.gov/ct2/show/NCT00676715. CommentRecommendBookmarkWatch
